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ABSTRACT BODY: 
Abstract Body: Background 
Identifying high performing CF centres can drive learning and inform quality improvement, but outcomes such as
FEV1 or exacerbations are insensitive to change at a centre level. Randomised controlled trials with adequate sample
size have shown that maintenance inhaled therapies will result in various important outcomes such as improved FEV1
or decreased exacerbations. This allows adherence rates to inhaled therapy (a process measure) to be used as a
quality indicator to identify highly performing centres.
Objective monitoring of adherence to inhaled therapy using chipped nebulisers suggests that median adherence in
adults is only 36% (Daniels T et al, Chest 2011; 140: 425-32). However, these data are based on nebulisers brought
to clinic and it is important to understand adherence rates in the nebulisers that are never brought to clinic.
 
Aim 
To explore the effects of missing data on the nebuliser adherence rates of an adult CF centre
 
Methods 
This is a retrospective analysis of adherence data measured with the I-neb nebuliser for both 2013 and 2014 in the
Sheffield Adult CF Centre. Adherence is calculated as 'normative adherence' (Hoo ZH et al, Patient Prefer Adherence
2016; 10: 1-14) which takes into account a patient's characteristics when defining the minimum required treatment
regime. People just on non-chipped devices for inhaled therapy, on ivacaftor or with previous lung transplantation
were excluded. Every person had at least 3 months瀞 worth of adherence data.
Two potential causes of missing data were considered:
(1) I-neb that were difficult to obtain for download (defined as people with data download <3 months for a particular
year, whose I-neb was only downloaded in a subsequent year)
(2) people not using any forms of inhaled therapy who should have been according to their clinical characteristics
(based on the definitions in Hoo ZH et al, Patient Prefer Adherence 2016; 10: 1-14)
 
Results 
89/166 (53.6%) of adults in 2013 and 97/170 (57.1%) of adults in 2014 were using I-nebs. For both 2013 and 2014,
only measuring adherence from I-neb that were easily obtainable over-estimated the overall centre adherence.
Adherence rates fell further if people not on any inhaled therapy but their clinical characteristics suggested they should
be on inhaled therapy were included in the overall estimate of centre adherence.
 
Conclusions 
Nebuliser data were not missing at random. Adherence levels fell after including difficult to obtain nebuliser in the
analysis and accounting for the population that are not on any inhaled therapy. A quality indicator in CF based on
nebuliser adherence needs to consider data completeness in comparing the adherence rates of different centres.



































































< 0.001 39.6 (14.6 -
65.4)
N = 97
33.6 (5.7 -
61.1)
N = 116
(No Image Selected)
